NPO Petrovax Pharm LLC together with Federal State Budgetary Institution The Gamaleya National Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation have completed the substance synthesis technology transfer, a key milestone for the project intended to localize Fabagal® production
This site contains information for medical and pharmaceutical professionals.
To view the content, please, confirm that you have the appropriate qualifications.